Gene: MYOM3
Official Full Name: myomesin 3provided by HGNC
Gene Summary: Predicted to enable protein homodimerization activity. Predicted to be involved in sarcomere organization. Predicted to be located in cytoplasm. Predicted to be active in M band. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27081 | MYOM3 Knockout cell line (HeLa) | Human | MYOM3 | 1:3~1:6 | Negative | Online Inquiry |
KO27082 | MYOM3 Knockout cell line (HCT 116) | Human | MYOM3 | 1:2~1:4 | Negative | Online Inquiry |
KO27083 | MYOM3 Knockout cell line (A549) | Human | MYOM3 | 1:3~1:4 | Negative | Online Inquiry |
MYOM3 Gene Knockout Cell Lines are innovative biological tools that facilitate the study of gene function and disease mechanisms by providing researchers with cell lines where the MYOM3 gene has been selectively inactivated. The MYOM3 gene is known to play a significant role in muscle development and function, making these knockout cell lines vital for investigating muscular disorders and associated pathologies.
The key function of MYOM3 Gene Knockout Cell Lines lies in their ability to allow researchers to examine the impact of the absence of MYOM3 on cellular processes, including muscle cell differentiation, proliferation, and contractility. By leveraging CRISPR-Cas9 technology, these cell lines exhibit a precise and stable knockout of the MYOM3 gene, significantly enhancing the reliability of experimental outcomes. This level of specificity eliminates off-target effects commonly associated with other gene-editing methods.
The scientific importance of these cell lines is underscored by their applications in both research and clinical settings. They serve as a robust model for investigating genetic regulation of muscle disorders, enabling researchers to elucidate the mechanisms underlying diseases such as muscular dystrophies and provide potential pathways for therapeutic intervention. Furthermore, MYOM3 Gene Knockout Cell Lines can be utilized in drug screening assays, biomarker identification, and developing targeted gene therapies.
What sets MYOM3 Gene Knockout Cell Lines apart from alternatives on the market is their unparalleled specificity and reproducibility, which are critical for obtaining valid and translatable research results. Researchers benefit from the comprehensive validation and characterizations conducted during the development process, ensuring that each cell line meets high-quality standards.
In addition, the value of MYOM3 Gene Knockout Cell Lines extends beyond their immediate use in experiments; they facilitate a deeper understanding of fundamental biological processes, thus providing a foundation upon which groundbreaking therapeutic strategies can be developed. As a leader in the field of biological products, our company combines expertise in molecular biology and genetics to deliver products that empower researchers and clinicians toward innovative discoveries in muscle biology and related fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.